DK184088A - Fremgangsmaade til oprensning af et polypeptid - Google Patents

Fremgangsmaade til oprensning af et polypeptid

Info

Publication number
DK184088A
DK184088A DK184088A DK184088A DK184088A DK 184088 A DK184088 A DK 184088A DK 184088 A DK184088 A DK 184088A DK 184088 A DK184088 A DK 184088A DK 184088 A DK184088 A DK 184088A
Authority
DK
Denmark
Prior art keywords
polypeptide
purification
procedure
Prior art date
Application number
DK184088A
Other languages
English (en)
Other versions
DK174968B1 (da
DK184088D0 (da
Inventor
Michael J Griffith
Gerald Neslund
Shu-Len Liu
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26708905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK184088(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of DK184088D0 publication Critical patent/DK184088D0/da
Publication of DK184088A publication Critical patent/DK184088A/da
Application granted granted Critical
Publication of DK174968B1 publication Critical patent/DK174968B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK198801840A 1987-03-31 1988-04-05 Fremgangsmåde til ultraoprensning af faktor VIII:C DK174968B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3280087A 1987-03-31 1987-03-31
US3280087 1987-03-31
US16790288A 1988-03-28 1988-03-28
US16790288 1988-03-28

Publications (3)

Publication Number Publication Date
DK184088D0 DK184088D0 (da) 1988-04-05
DK184088A true DK184088A (da) 1988-10-01
DK174968B1 DK174968B1 (da) 2004-04-05

Family

ID=26708905

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801840A DK174968B1 (da) 1987-03-31 1988-04-05 Fremgangsmåde til ultraoprensning af faktor VIII:C

Country Status (7)

Country Link
US (1) US5470954C1 (da)
EP (1) EP0286323B1 (da)
JP (1) JP2686766B2 (da)
CA (1) CA1339946C (da)
DE (1) DE3886249T2 (da)
DK (1) DK174968B1 (da)
ES (1) ES2061642T3 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010709A2 (en) * 1989-03-14 1990-09-20 Board Of Regents Of The University Of Nebraska Monoclonal antibodies for metallic cations on small molecules
US5639624A (en) * 1989-03-14 1997-06-17 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for metallic cations and method therefor
JPH0327109A (ja) * 1989-06-24 1991-02-05 Hagiwara Kogyo Kk 生物分解性フラットヤーンの製造方法
AT402153B (de) * 1989-06-26 1997-02-25 Immuno Ag Protein-s-hältige pharmazeutische präparation
US5254532A (en) * 1989-06-26 1993-10-19 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
JPH0427865A (ja) * 1989-12-21 1992-01-30 Kurita Water Ind Ltd 血液凝固因子用分離剤およびその製造方法
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
WO1994017415A1 (en) 1993-01-29 1994-08-04 Dahlbaeck Bjoern Novel anticoagulant cofactor activity
DE4337573C1 (de) * 1993-11-04 1995-05-18 Octapharma Ag Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden
US5589571A (en) * 1994-10-28 1996-12-31 Cor Therapeutics, Inc. Process for production of inhibited forms of activated blood factors
SE503424C2 (sv) * 1994-11-14 1996-06-10 Pharmacia Ab Process för rening av rekombinant koagulationsfaktor VIII
US6111079A (en) * 1995-06-05 2000-08-29 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefore
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
US6121428A (en) 1997-06-13 2000-09-19 Genentech, Inc. Protein recovery
US7820796B2 (en) * 1998-03-12 2010-10-26 Genetics Institute, Llc. Methods for producing Factor VIII proteins
EP1062244B1 (en) * 1998-03-12 2002-08-28 Genetics Institute, LLC Improved methods for producing factor viii proteins
BRPI9910332B8 (pt) * 1998-05-06 2021-05-25 Genentech Inc método para purificação de um polipeptídio a partir de uma composição
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
BRPI0519562A2 (pt) 2004-12-27 2009-01-27 Baxter Int construÇço proteinÁcea, complexo, mÉtodo para prolongar a meia-vida in vivo de fator viii (fviii) ou um derivado biologicamente ativo do mesmo composiÇço farmacÊutica, e, mÉtodo para formar uma construÇço proteinÁcea
CN1302009C (zh) * 2005-09-05 2007-02-28 武汉海特生物制药股份有限公司 用有机溶剂病毒灭活法制备鼠神经生长因子的工艺
KR20080108147A (ko) * 2006-03-31 2008-12-11 백스터 인터내셔널 인코포레이티드 페질화된 인자 ｖｉｉｉ
US7645860B2 (en) 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
KR100791502B1 (ko) 2006-09-29 2008-01-03 한스바이오메드 주식회사 바이러스 불활화된 무세포 인체 이식재 생산방법
DK2242479T3 (da) * 2007-12-28 2012-01-02 Baxter Int Modtryksfiltrering af proteiner
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
EA032336B1 (ru) * 2010-09-17 2019-05-31 Баксалта Инкорпорейтид Стабильная водная иммуноглобулиновая композиция и способ стабилизации иммуноглобулиновой композиции
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
SG191781A1 (en) * 2010-12-30 2013-08-30 Lab Francais Du Fractionnement Glycols as pathogen inactivating agents
PT4241849T (pt) 2011-10-14 2024-10-30 Hoffmann La Roche Utilizações do inibidor da dimerização de her2 pertuzumab e artigo de fabrico que inclui o mesmo
AU2012324020A1 (en) * 2011-12-30 2013-07-18 Grifols, S.A. Method for purifying Factor VIII
US9700486B2 (en) 2013-04-24 2017-07-11 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
WO2014201400A2 (en) * 2013-06-13 2014-12-18 Biogen Idec Ma Inc. Anti-factor viii antibodies or uses thereof
EP3506915B1 (en) 2016-09-01 2024-03-06 Plas-Free Ltd Human blood-derived products having decreased fibrinolytic activity and uses thereof in hemostatic disorders
MY189536A (en) 2017-01-17 2022-02-16 Hoffmann La Roche Subcutaneous her2 antibody formulations
US11077189B2 (en) 2017-03-02 2021-08-03 Genentech Inc. Adjuvant treatment of HER2-positive breast cancer
PL3661636T3 (pl) * 2017-08-04 2024-03-18 Takeda Pharmaceutical Company Limited Aparatura i sposoby do sprzęgania przeciwciał z żywicą
EP4171748A1 (en) 2020-06-29 2023-05-03 Genentech, Inc. Pertuzumab plus trastuzumab fixed dose combination
EP4240757A2 (en) 2020-11-09 2023-09-13 Takeda Pharmaceutical Company Limited Purification of fviii from plasma using silicon oxide adsorption

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses
US4086218A (en) * 1975-04-11 1978-04-25 Edward Shanbrom, Inc. Method of preserving blood plasma II
US4188318A (en) * 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
DE2550011C2 (de) * 1975-11-07 1982-11-25 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines antihämophilen Mittels
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
US4315919A (en) * 1980-10-06 1982-02-16 Edward Shanbrom Depyrogenation process
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
JPS58500127A (ja) * 1981-02-26 1983-01-20 ユニリ−バ−　ナ−ムロ−ゼ　ベンノ−トシヤ−プ 回収
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
US4485017A (en) * 1982-12-22 1984-11-27 Cetus Corporation Isolation of human interferon by immunosorbent and high performance liquid chromatography
US4558006A (en) * 1983-02-04 1985-12-10 Kirin-Amgen, Inc. A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
US5214033A (en) * 1983-03-31 1993-05-25 Scripps Clinic & Research Foundation Factor VIII coagulant polypeptides
FI841281A7 (fi) * 1983-03-31 1984-10-01 Scripps Clinic And Res Foundation VIII koagulantti-polypeptidien uusi tekijä ja niiden monoklonaaliset vasta-aineet.
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3486350T2 (de) * 1983-10-28 1995-03-16 New England Medical Center Inc VERFAHREN ZUR ISOLIERUNG EINES PROTEINS AUS EINER DIESES PROTEIN ENTHALTENDEN MISCHUNG UNTER VERWENDUNG EINES KONFORMATIONSSPEZIFISCHEN ANTIKöRPERS.
DE3586402T3 (de) * 1984-01-12 2004-12-23 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Proteinzusammensetzung mit Koagulations-wirkung und Verfahren zu ihrer Herstellung.
US4578335A (en) * 1984-05-21 1986-03-25 Immunex Corporation Interleukin 2 receptor
EP0188589A1 (en) * 1984-07-30 1986-07-30 Celltech Limited Immunopurification process
JPS6151000A (ja) * 1984-08-17 1986-03-13 Toray Ind Inc ヒト・インタ−フエロンβの精製法
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
JPS61145200A (ja) * 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
JPS61242593A (ja) * 1985-04-19 1986-10-28 Toray Ind Inc ヒト・インタ−フエロンβの精製法
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
US4740306A (en) * 1986-03-17 1988-04-26 Temple University - Of The Commonwealth System Of Higher Education Chromatographic column
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
US4765903A (en) * 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon

Also Published As

Publication number Publication date
US5470954A (en) 1995-11-28
JPS6413099A (en) 1989-01-17
DE3886249T2 (de) 1994-06-30
EP0286323A3 (en) 1988-11-17
DE3886249D1 (de) 1994-01-27
JP2686766B2 (ja) 1997-12-08
EP0286323A2 (en) 1988-10-12
DK174968B1 (da) 2004-04-05
ES2061642T3 (es) 1994-12-16
US5470954C1 (en) 2001-02-06
CA1339946C (en) 1998-07-07
EP0286323B1 (en) 1993-12-15
DK184088D0 (da) 1988-04-05

Similar Documents

Publication Publication Date Title
DK184088D0 (da) Fremgangsmaade til oprensning af et polypeptid
DK271482A (da) Fremgangsmaade til fremstilling af et polypeptid
ES542309A0 (es) Procedimiento para obtener un polipeptido purificado
NO843592L (no) Fremgangsmaate for fremstilling av et polypeptid
DK513988D0 (da) Fremgangsmaade til rensning af roeggas
DK496486A (da) Polypeptid
DK609885D0 (da) Fremgangsmaade til modifikation af organismer
DK549688D0 (da) Fremstilling af peptider
DK551287D0 (da) Polypeptid
DK383985A (da) Polypeptid
DK354389D0 (da) Polypeptid
DK220983D0 (da) Fremgangsmade til fremstilling af et cyclisk peptidderivat benaevnt a-21978c
DK410481A (da) Fremgangsmaade til fremstilling af et polypeptid
DK273089D0 (da) Anvendelse af peptidderivater
DK221283D0 (da) Fremgangsmade til fremstilling af et cyclisk peptidderivat benaevnt a-21978c
DK589089D0 (da) Anvendelse af benzomorphaner til cytoprotektion
DK241688D0 (da) Fremgangsmaade til fremstilling af fusionsproteiner
DK341188A (da) Fremgangsmaade til fremstilling af en vaeskeabsorberende pude
DK664789A (da) Fremgangsmaade til hydroaminering af olefiner
DK725788D0 (da) Fremgangsmaade til fremstilling af kanelsyreestre
DK457788D0 (da) Fremgangsmaade til fremstilling af et oensket polypeptid
DK223188D0 (da) Fremgangsmaade til fremstilling af l-phenylalanin ved hjaelp af rekombinante bakterier
DK665588D0 (da) Fremgangsmaade til rensning af et polypeptid og polypeptid
DK450087D0 (da) Fremgangsmaade til fremstilling af proteiner
DK63489A (da) Fremgangsmaade til spaltning af fusionsproteiner

Legal Events

Date Code Title Description
PUP Patent expired